studies have been reported further buttressing my proposition of different criteria for defining overweight and obesity for Asian ethnic groups.
In response to the first point raised by June Stevens, we shall briefly review the recent data showing excess cardiovascular morbidity at the 'normal' range of body mass index (BMI) in the Asian populations. In Hong Kong Chinese men, the optimal BMI cutoff to predict diabetes, hypertension and dyslipidemia was lower than currently recommended for the diagnosis of obesity. 3 Similar data showing high cardiovascular-related morbidities at upper 'normal' BMI range have been reported for the ethnic groups in several Asian countries: Korea, 4 Singapore, 5 Japan, 6 and Taiwan. 7 Our recent data on Asian Indians residing in New Delhi, India, showed that B66% men and 88% women, classified as 'nonobese' based on BMI, had Z1 cardiovascular risk factor(s). Significantly higher odds ratios for hypertension, diabetes mellitus and hypertriglyceridemia were observed in 'nonobese' subjects having upper quartiles as compared to the lowermost quartile of percentage of body fat. 8 Further, in a subgroup analysis of our investigation in the young adults, 9 we observed similar C-reactive protein (CRP) levels in subjects in the BMI range of 23. In reference to the second point raised by June Stevens, I am in complete agreement that BMI-mortality association adds important information to BMI-body fat and BMIcardiovascular morbidity data, and is vital for the development of accurate definition of healthy and normal weight and BMI. However, BMI-mortality association of a given population is modulated by several factors other than the cardiovascular morbidity statistics. For example, availability and standards of medical services differ substantially between the developed and developing countries, and according to the socioeconomic strata, and may make comparison of BMI-mortality association across various ethnic groups difficult, or even fallacious. Further, the prevalence of smoking varies depending on the ethnic group, and introduces a significant confounding in the interpretation of the mortality data. Finally, increasing prevalence of acquired immunodeficiency syndrome in the Asian countries and its coexistence with already prevalent tuberculosis may further jeopardize data on all-cause mortality in adults if excess cardiovascular-related mortality association is the desired target for analysis. While the study quoted by the authors 11 Age-adjusted all-cause mortality data, and incidence rates for coronary heart disease and stroke indicated a lower BMI cutoff for defining overweight. Significantly, the Working Group suggested that decreasing the BMI limit to 24 kg/m 2 for the diagnosis of overweight would prevent the incidence of coronary heart disease and stroke by 11 and 15% in men, respectively, and by 22% for both diseases in women, in the Chinese population.
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The overall pattern of the available data in the Asian populations appears logical, and in line with the current understanding of pathophysiology of cardiovascular morbidities due to excess adipose tissue. Simply put, Asian ethnic groups have higher body fat at a 'normal' range of BMI, and excess body fat raises cardiovascular morbidities at the 'nonobese' BMI range, and increases all-cause mortality. Importantly, the data are consistently uniform regardless of the country of residence, socioeconomic strata, and physical activity profile of any given ethnic group. For example, excess body fat and morbidities at 'non obese' BMI range have been demonstrated for Asian Indians in several countries and belonging to diverse socioeconomic strata, 5, 8, [15] [16] [17] and similar data exist for the Chinese populations.
To some extent, such investigations also provide answer to final argument of June Stevens regarding possible variation of BMI depending on the physical activity pattern. However, it is known that physical activity profile is perhaps the least studied and most difficult to assess among all the cardiovascular risk factors. Clearly, more studies will be required to investigate this issue. The concept of 'duality' of cutoff points for defining overweight and obesity, one for 'universal' use and another for 'individual country use' may be circumspect when implementing national programs for obesity, diabetes and cardiovascular diseases in the individual countries. While the policy planners in the Asian countries are aiming to provide simple and definitive guidelines for physicians to implement, and clear messages for the general population to follow, such 'dual' definitions may generate a great deal of confusion. Rapidly accumulating credible and persuasive data now support lower BMI cutoffs for the Asian populations. The national policy statements for the individual Asian countries, thus, should project this revised single definition for overweight and obesity. Practical impediments may be encountered in case the concept of 'dual' definition of obesity becomes operative globally. An obvious problem will be its implementation in countries with multiethnic populations.
Finally, it is not only the BMI that needs revision for the Asian populations; there are some data to suggest that the limits of waist circumference should also be revised. A large study in the Chinese population (n ¼ 111, 411) suggested lower limits for the waist circumference, 85 cm for men and 80 cm for women, according to the cardiovascular morbidity profile. 10 Our recent data showed significantly high odds ratios for hypertriglyceridemia and hypertension among 'non obese' males who had waist circumference within the 'normal' range. 8 Lower cutoffs for waist circumference to define abdominal obesity than those recommended universally have been proposed in another study in the Chinese population, 3 Revision of definition of BMI for the Asian populations will not result in 'loss of identity of the disease' as stated by June Stevens, but, on the other hand, will put obesity in the forefront of the health agenda of many developing countries in Asia. Indeed, 'Cardiovascular Diseases Prevention Programs' in many Asian countries, particularly developing countries, are likely to be rejuvenated and also get the necessary financial inputs in case of such an action. Understandably, the matter assumes great importance since more than half of the world's population resides in the Asian countries and benefits accruing by implementing the revised guidelines for overweight and obesity will be applicable to B15% of such populations. This task may also help in halting the 'epidemic' of cardiovascular diseases in many developing countries.
